088264552	088264552	CD	B-NP	O
|	|	NN	I-NP	O
INIMC	INIMC	NN	I-NP	O
|	|	NN	I-NP	O
39713635	39713635	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9900436	9900436	CD	B-NP	O
|	|	CC	I-NP	O
9/23/2007	9/23/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
s/p	s/p	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
and	and	CC	O	O
stenting	stente	VBG	B-VP	O
|	|	NNP	B-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/17/2007	6/17/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/17/2007	11/17/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
LASELL	LASELL	NNP	B-NP	O
,	,	,	O	O
REFUGIO	REFUGIO	NNP	B-NP	O
D.	D.	NNP	I-NP	O
031-08-99-2	031-08-99-2	CD	I-NP	O
Liskoohelicarn	Liskoohelicarn	NNP	I-NP	O
Rd.	Rd.	NNP	I-NP	O
.	.	.	O	O

Service	Service	NN	B-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
2/23/07	2/23/07	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
VILLASIS	VILLASIS	NNP	B-NP	O
,	,	,	O	O
JR	JR	NNP	B-NP	O
,	,	,	O	O
ALPHONSO	ALPHONSO	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ASPIRIN	ASPIRIN	NNP	B-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	VBD	B-VP	O
325	325	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

FENOFIBRATE	FENOFIBRATE	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
TRICOR	TRICOR	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
48	48	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

MYCOPHENOLATE	MYCOPHENOLATE	JJ	B-NP	B-protein
MOFETIL	MOFETIL	NN	I-NP	I-protein
1000	1000	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

OXYBUTYNIN	OXYBUTYNIN	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
XL	XL	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

PRAVASTATIN	PRAVASTATIN	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

INSULIN	INSULIN	NN	B-NP	B-protein
GLARGINE	GLARGINE	NN	I-NP	I-protein
20	20	CD	B-NP	I-protein
UNITS	UNITS	NNS	I-NP	I-protein
SC	SC	NN	I-NP	I-protein
QAM	QAM	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

FUROSEMIDE	FUROSEMIDE	NNP	B-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	B-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

THERAPEUTIC	THERAPEUTIC	NN	B-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

PREDNISONE	PREDNISONE	NN	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

CYCLOSPORINE	CYCLOSPORINE	NN	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
SANDIMMUNE	SANDIMMUNE	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
75	75	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
12	12	CD	I-NP	I-protein
.	.	.	O	O

METOPROLOL	METOPROLOL	NNP	B-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
FERROUS	FERROUS	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
ENTERIC	ENTERIC	NN	I-NP	I-protein
COATED	COATED	VBD	B-VP	I-protein
ASA	ASA	NN	B-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
PLAVIX	PLAVIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
75	75	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Tomorrow	Tomorrow	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
10/9	10/9	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NN	I-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SANDIMMUNE	SANDIMMUNE	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	O	I-DNA
75	75	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/26/07	5/26/07	CD	B-NP	O
by	by	IN	B-PP	O
WHITTON	WHITTON	NNP	B-NP	O
,	,	,	O	O
PARKER	PARKER	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
PRAVACHOL	PRAVACHOL	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
531956404	531956404	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
PRAVASTATIN	PRAVASTATIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
taking	take	VBG	B-VP	O
as	as	RB	B-NP	O
outpatient	outpatient	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/26/07	5/26/07	CD	B-NP	O
by	by	IN	B-PP	O
MILKENT	MILKENT	NNP	B-NP	O
,	,	,	O	O
LUTHER	LUTHER	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TRICOR	TRICOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
281706887	281706887	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
,	,	,	O	O
MICRONIZED	MICRONIZED	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
taking	take	VBG	B-VP	O
as	as	IN	B-SBAR	O
outpatient	outpatient	NN	B-NP	O
TRICOR	TRICOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TRICOR	TRICOR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
48	48	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/26/07	5/26/07	CD	B-NP	O
by	by	IN	B-PP	O
TOBAR	TOBAR	NN	B-NP	B-protein
,	,	,	O	O
CARY	CARY	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
PRAVACHOL	PRAVACHOL	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
531956404	531956404	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FENOFIBRATE	FENOFIBRATE	NNP	B-NP	O
,	,	,	I-NP	O
MICRONIZED	MICRONIZED	NNP	I-NP	O
&	&	CC	I-NP	O
PRAVASTATIN	PRAVASTATIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
taking	take	VBG	B-VP	O
as	as	RB	B-NP	O
outpatient	outpatient	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/26/07	5/26/07	CD	B-NP	O
by	by	IN	B-PP	O
HOUGHAM	HOUGHAM	NNP	B-NP	O
,	,	,	O	O
LOUIS	LOUIS	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
,	,	,	O	O
MICRONIZED	MICRONIZED	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
taking	take	VBG	B-VP	O
as	as	IN	B-SBAR	O
outpatient	outpatient	NN	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/27	10/27	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
CELLCEPT	CELLCEPT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
MYCOPHENOLATE	MYCOPHENOLATE	NN	I-NP	O
MOFETIL	MOFETIL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food	Food	NNP	I-NP	O
decreases	decrease	VBZ	B-VP	O
peak	peak	NN	B-NP	O
by	by	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
DITROPAN	DITROPAN	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OXYBUTYNIN	OXYBUTYNIN	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
PRAVACHOL	PRAVACHOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PRAVASTATIN	PRAVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/26/07	5/26/07	CD	B-NP	O
by	by	IN	B-PP	O
NOTHSTINE	NOTHSTINE	NNP	B-NP	O
,	,	,	O	O
DANE	DANE	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
PRAVACHOL	PRAVACHOL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
531956404	531956404	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
muscle	muscle	NN	B-NP	O
aches	ache	NNS	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
pravastatin	pravastatin	NN	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/26/07	5/26/07	CD	B-NP	O
by	by	IN	B-PP	O
SOCHOCKI	SOCHOCKI	NNP	B-NP	O
,	,	,	O	O
BRADLEY	BRADLEY	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
PRAVASTATIN	PRAVASTATIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FENOFIBRATE	FENOFIBRATE	NNP	B-NP	O
,	,	,	I-NP	O
MICRONIZED	MICRONIZED	NNP	I-NP	O
&	&	CC	I-NP	O
PRAVASTATIN	PRAVASTATIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
taking	take	VBG	B-VP	O
as	as	IN	B-SBAR	O
outpatient	outpatient	NN	B-NP	O
PREDNISONE	PREDNISONE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
light	light	NN	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
heavy	heavy	JJ	I-NP	O
lifting	lift	VBG	I-NP	O
or	or	CC	I-VP	O
driving	drive	VBG	I-VP	O
x	x	NN	B-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

ok	ok	NN	B-NP	O
to	to	TO	B-VP	O
shower	shower	VB	I-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
swimming	swimming	NN	I-NP	O
or	or	CC	I-NP	O
bathing	bathing	NN	I-NP	O
x	x	SYM	B-NP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
Lift	Lift	NN	B-NP	O
restrictions	restriction	NNS	I-NP	O
:	:	:	O	O
Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
lift	lift	VB	I-VP	O
greater	great	JJR	B-NP	O
then	then	RB	B-ADVP	O
10-15	10-15	CD	B-NP	O
pounds	pound	NNS	I-NP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Heart	Heart	NNP	B-NP	O
transplant	transplant	NN	I-NP	O
Clinic	Clinic	NNP	B-NP	O
2-4	2-4	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
and	and	CC	O	O
stenting	stente	VBG	B-VP	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
s/p	s/p	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
1992	1992	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Diabetes	Diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Trochanteric	Trochanteric	JJ	I-NP	O
bursitis	bursitis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
trochanteric	trochanteric	JJ	I-NP	O
bursitis	bursitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Dyslipidemia	Dyslipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DJD	DJD	NN	I-NP	O
spine	spine	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
OA	OA	NN	I-NP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
spine	spine	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hx	Hx	NN	I-NP	O
vocal	vocal	JJ	I-NP	O
cord	cord	NN	I-NP	O
injury	injury	NN	I-NP	O
postop	postop	VBP	B-VP	O
Hx	Hx	NN	B-NP	O
gastritis	gastritis	NN	I-NP	O
with	with	IN	B-PP	O
UGIB	UGIB	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
upper	upper	JJ	I-NP	O
GI	GI	NN	I-NP	O
bleeding	bleed	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	O
Hx	Hx	NN	I-NP	O
postop	postop	VBP	B-VP	O
seizure	seizure	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
and	and	CC	O	O
stenting	stente	VBG	B-VP	O
BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Josef	Josef	NNP	B-NP	O
Chandley	Chandley	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
71-year-old	71-year-old	JJ	I-NP	O
white	white	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
transplantation	transplantation	NN	I-NP	O
on	on	IN	B-PP	O
1/27/1992	1/27/1992	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
important	important	JJ	B-NP	O
posttransplant	posttransplant	NN	I-NP	O
medical	medical	JJ	I-NP	O
issues	issue	NNS	I-NP	O
including	include	VBG	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
had	have	VBD	I-VP	O
significant	significant	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
including	include	VBG	B-PP	O
allograft	allograft	NN	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
carotid	carotid	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
stenting	stente	VBG	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
artery	artery	NN	I-NP	O
in	in	IN	B-PP	O
9/6	9/6	CD	B-NP	O
and	and	CC	O	O
stenting	stente	VBG	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
artery	artery	NN	I-NP	O
in	in	IN	B-PP	O
5/2	5/2	CD	B-NP	O
In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
9/6	9/6	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
stenting	stente	VBG	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
2/20	2/20	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
stenting	stente	VBG	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
additional	additional	JJ	B-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
for	for	IN	B-PP	O
some	some	DT	B-NP	O
or	or	CC	I-NP	O
all	all	DT	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
now	now	RB	B-ADVP	O
returns	return	VBZ	B-VP	O
for	for	IN	B-PP	O
repeat	repeat	NN	B-NP	O
intervention	intervention	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
PCI	PCI	NN	I-NP	O
Notes	Note	NNS	I-NP	O
--	--	:	O	O
Complicated	Complicate	VBN	B-NP	O
bifurcation	bifurcation	NN	I-NP	O
lesion	lesion	NN	I-NP	O
of	of	IN	B-PP	O
mLCX	mLCX	NN	B-NP	O
involving	involve	VBG	B-VP	O
OM1	OM1	NN	B-NP	B-protein
and	and	CC	I-NP	O
OM2	OM2	NN	I-NP	B-protein
.	.	.	O	O

Bifurcation	Bifurcation	NN	B-NP	O
ultimately	ultimately	RB	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
``	``	``	O	O
coulotte	coulotte	NN	B-NP	O
''	''	''	O	O
stenting	stente	VBG	B-VP	O
with	with	IN	B-PP	O
2.5	2.5	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
28	28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cypher	Cypher	NNP	I-NP	O
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
branch	branch	NN	I-NP	O
and	and	CC	I-NP	O
2.5	2.5	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
18	18	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cypher	Cypher	NNP	I-NP	O
in	in	IN	B-PP	O
upper	upper	JJ	B-NP	O
branch	branch	NN	I-NP	O
.	.	.	O	O

Kissing	Kiss	VBG	B-VP	O
balloon	balloon	NN	B-NP	O
inflations	inflation	NNS	I-NP	O
performed	perform	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
dissection	dissection	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
OM	OM	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
.	.	.	O	O

Likely	Likely	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
coronary	coronary	JJ	B-NP	O
guidewire	guidewire	NN	I-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
tortous	tortous	JJ	I-NP	O
vessel	vessel	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
distal	distal	JJ	I-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
dissection	dissection	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
elected	elect	VBD	B-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
further	further	RBR	B-ADVP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
tolerated	tolerate	VBD	B-VP	O
procedure	procedure	NN	B-NP	O
well	well	RB	B-ADVP	O
without	without	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
.	.	.	O	O

Started	Started	JJ	B-NP	B-protein
integrilin	integrilin	NN	I-NP	I-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
for	for	IN	B-PP	O
18	18	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
remain	remain	VB	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
for	for	IN	B-PP	O
life	life	NN	B-NP	O
and	and	CC	I-NP	O
clopidogrel	clopidogrel	NN	I-NP	O
indefinitely	indefinitely	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
CK	CK	NN	I-NP	O
's	's	POS	B-NP	O
checked	check	VBD	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Cr	Cr	NNP	B-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
AM	AM	NN	B-NP	O
.	.	.	O	O

SSI	SSI	NN	B-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

Mucomyst	Mucomyst	NN	B-NP	O
and	and	CC	I-NP	O
IVF	IVF	NN	I-NP	B-protein
Manual	Manual	JJ	I-NP	O
8Fr	8Fr	NN	I-NP	O
sheath	sheath	NN	I-NP	O
removed	remove	VBN	B-VP	O
from	from	IN	B-PP	O
Rt	Rt	NNP	B-NP	O
CFA	CFA	NNP	I-NP	O
.	.	.	O	O

7/26	7/26	CD	B-NP	O
Pt	Pt	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADJP	O
overnight	overnight	JJ	I-ADJP	O
.	.	.	O	O

groin	groin	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
without	without	IN	B-PP	O
hematoma	hematoma	NN	B-NP	O
,	,	,	O	O
bruit	bruit	NN	B-NP	O
.	.	.	O	O

denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
groin/flank	groin/flank	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

bp	bp	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

ck	ck	NN	B-NP	O
's	's	POS	B-NP	O
flat	flat	NN	I-NP	O
.	.	.	O	O

hct	hct	NN	B-NP	O
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
26	26	CD	B-NP	O
from	from	IN	B-PP	O
32	32	CD	B-NP	O
-	-	HYPH	O	O
likely	likely	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
prlonged	prlonged	JJ	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

will	will	MD	B-VP	O
repeat	repeat	VB	I-VP	O
to	to	TO	I-VP	O
make	make	VB	I-VP	O
ure	ure	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
prior	prior	JJ	B-ADVP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
-	-	HYPH	O	O
you	you	PRP	B-NP	O
must	must	MD	B-VP	O
take	take	VB	I-VP	O
aspirin	aspirin	NN	B-NP	O
for	for	IN	B-PP	O
life	life	NN	B-NP	O
-	-	HYPH	O	O
you	you	PRP	B-NP	O
must	must	MD	B-VP	O
take	take	VB	I-VP	O
plavix	plavix	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
year	year	NN	I-NP	O
DO	DO	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
STOP	STOP	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
OR	OR	NNP	I-NP	O
PLAVIX	PLAVIX	NNP	I-NP	O
FOR	FOR	NNP	I-NP	O
ANY	ANY	NNP	I-NP	O
REASON	REASON	NNP	I-NP	O
UNLESS	UNLESS	NNP	I-NP	O
SPEAK	SPEAK	NNP	I-NP	O
WITH	WITH	NNP	I-NP	O
YOUR	YOUR	NNP	I-NP	O
CARDIOLOGIST	CARDIOLOGIST	NN	I-NP	O
!	!	.	O	O

-	-	HYPH	B-NP	O
resume	resume	VBP	B-VP	O
other	other	JJ	B-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
usual	usual	JJ	B-NP	O
doses	dose	NNS	I-NP	O
-	-	HYPH	B-NP	O
continue	continue	JJ	I-NP	O
iron	iron	NN	I-NP	O
supplements	supplement	NNS	I-NP	O
at	at	IN	B-PP	O
usual	usual	JJ	B-NP	O
dose	dose	NN	I-NP	O
and	and	CC	O	O
report	report	VB	B-VP	O
any	any	DT	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
immediately	immediately	RB	B-ADVP	O
-	-	HYPH	B-NP	O
call	call	NN	I-NP	O
with	with	IN	B-PP	O
questions	question	NNS	B-NP	O
or	or	CC	I-NP	O
concerns	concern	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BOUCHIE	BOUCHIE	NNP	B-NP	O
,	,	,	O	O
WILTON	WILTON	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
PA-C	PA-C	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
GI97	GI97	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
2/23/07	2/23/07	CD	B-NP	O
@	@	SYM	I-NP	O
09	09	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

